A late-July U.S.-EU trade deal capped most EU imports, including pharmaceuticals, at 15%, easing fears of triple-digit levies and supporting a rebound in life-sciences tools shares. On July 23, Thermo Fisher raised the lower end of guidance and said the tariff situation was improving, reinforcing the risk-relief trade. Danaher and Agilent also have reported their… The post As tariff relief lifts sector, Thermo Fisher pulls ahead while Waters continues to navigate $17.5B deal appeared first ...
